Related references
Note: Only part of the references are listed.An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients
James Gilleen et al.
PSYCHOPHARMACOLOGY (2021)
Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies
Dileep Vijayan et al.
CURRENT DRUG TARGETS (2020)
MicroRNA-134-5p inhibition rescues long-term plasticity and synaptic tagging/capture in an Aβ(1-42)-induced model of Alzheimer's disease
Nimmi Baby et al.
AGING CELL (2020)
Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease
Elisa Zuccarello et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Aging and Alzheimer's disease pathology
Renpei Sengoku
NEUROPATHOLOGY (2020)
Glycogen synthase kinase-3 signaling in Alzheimer's disease
Elisabetta Lauretti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Neuroprotective role of alendronate against APP processing and neuroinflammation in mice fed a high fat diet
Saima Zameer et al.
BRAIN RESEARCH BULLETIN (2020)
Engeletin Attenuates Aβ1-42-Induced Oxidative Stress and Neuroinflammation by Keap1/Nrf2 Pathway
Zhixiong Huang et al.
INFLAMMATION (2020)
Roflumilast attenuates cognitive deficits in estrogen insufficient rats
Ahsas Goyal et al.
BEHAVIOURAL PHARMACOLOGY (2020)
Sodium orthovanadate improves learning and memory in intracerebroventricular-streptozotocin rat model of Alzheimer's disease through modulation of brain insulin resistance induced tau pathology
Ansab Akhtar et al.
BRAIN RESEARCH BULLETIN (2020)
Loss of Protection by Antiepileptic Drugs in Lipopolysaccharide-primed Pilocarpine-induced Status Epilepticus is Mediated via Inflammatory Signalling
Preeti Vyas et al.
NEUROSCIENCE (2020)
Phosphodiesterase Inhibitors for Alzheimer's Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale
Owen Sanders et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2020)
The Interplay Between Beta-Amyloid 1-42 (Aβ1-42)-Induced Hippocampal Inflammatory Response, p-tau, Vascular Pathology, and Their Synergistic Contributions to Neuronal Death and Behavioral Deficits
Beatriz Calvo-Flores Guzman et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease
Syed Obaidur Rahman et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Alpha lipoic acid and metformin alleviates experimentally induced insulin resistance and cognitive deficit by modulation of TLR2 signalling
Swati Ahuja et al.
PHARMACOLOGICAL REPORTS (2019)
Tetraclinis articulata essential oil mitigates cognitive deficits and brain oxidative stress in an Alzheimer's disease amyloidosis model
Fatima Zahra Sadiki et al.
PHYTOMEDICINE (2019)
Tadalafil restores long-term memory and synaptic plasticity in mice with hepatic encephalopathy
Maria Eduarda Rocha Franca et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects
Huancun Feng et al.
METABOLIC BRAIN DISEASE (2019)
NMDA receptor in the hippocampus alters neurobehavioral phenotypes through inflammatory cytokines in rats with sporadic Alzheimer-like disease
Mohammad Amani et al.
PHYSIOLOGY & BEHAVIOR (2019)
Amentoflavone suppresses amyloid β1-42 neurotoxicity in Alzheimer's disease through the inhibition of pyroptosis
Ningning Zhao et al.
LIFE SCIENCES (2019)
Lactuca capensis reverses memory deficits in Aβ1-42-induced an animal model of Alzheimer's disease
Paula Alexandra Postu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Alzheimer's disease: clinical update on epidemiology, pathophysiology and diagnosis
Dhamidhu Eratne et al.
AUSTRALASIAN PSYCHIATRY (2018)
Cyclic nucleotide signaling changes associated with normal aging and age related diseases of the brain
Michy P. Kelly
CELLULAR SIGNALLING (2018)
Protective effects of evodiamine in experimental paradigm of Alzheimer's disease
Dongmei Wang et al.
COGNITIVE NEURODYNAMICS (2018)
Betulinic acid, a natural PDE inhibitor restores hippocampal cAMP/cGMP and BDNF, improve cerebral blood flow and recover memory deficits in permanent BCCAO induced vascular dementia in rats
Madhu Kaundal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Roflumilast promotes memory recovery and attenuates white matter injury in aged rats subjected to chronic cerebral hypoperfusion
Amanda Santiago et al.
NEUROPHARMACOLOGY (2018)
Sub-efficacious doses of phosphodiesterase 4 and 5 inhibitors improve memory in a mouse model of Alzheimer's disease
Walter Gulisano et al.
NEUROPHARMACOLOGY (2018)
Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations
P. R. A. Heckman et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Protective effect of betulinic acid against intracerebroventricular streptozotocin induced cognitive impairment and neuronal damage in rats: Possible neurotransmitters and neuroinflammatory mechanism
Madhu Kaundal et al.
PHARMACOLOGICAL REPORTS (2018)
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
Fuyuki Kametani et al.
FRONTIERS IN NEUROSCIENCE (2018)
Tannins Enriched Fraction of Emblica officinalis Fruits Alleviates High-Salt and Cholesterol Diet-Induced Cognitive Impairment in Rats via Nrf2-ARE Pathway
Ibraheem Husain et al.
FRONTIERS IN PHARMACOLOGY (2018)
Inhibition of Phosphodiesterase-4 Reverses Aβ-Induced Memory Impairment by Regulation of HPA Axis Related cAMP Signaling
Ying Xu et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
NAP Protects against Tau Hyperphosphorylation Through GSK3
Yanina Ivashko-Pachima et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions
Veronica Begni et al.
CLINICAL SCIENCE (2017)
Hyperglycemia and high nitric oxide level induced oxidative stress in the brain and molecular alteration in the neurons and glial cells of laboratory mouse, Mus musculus
Rashmi Richa et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita et al.
SCIENTIFIC REPORTS (2017)
Caffeic acid attenuates oxidative stress, learning and memory deficit in intra-cerebroventricular streptozotocin induced experimental dementia in rats
Rahul Deshmukh et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior
Sheetal Sharma et al.
NEUROLOGICAL RESEARCH (2016)
Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt/GSK-3β pathway
Yan-Juan Wang et al.
ONCOTARGET (2016)
Roflumilast: a review of its use in the treatment of COPD
Jadwiga A. Wedzicha et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
Brain-derived neurotrophic factor and its clinical implications
Siresha Bathina et al.
ARCHIVES OF MEDICAL SCIENCE (2015)
Oxidant/Antioxidant Imbalance and the Risk of Alzheimer's Disease
Ahmed E. Abdel Moneim
CURRENT ALZHEIMER RESEARCH (2015)
Lycopene abrogates Aβ(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease
Anand Kamal Sachdeva et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)
Object memory enhancement by combining sub-efficacious doses of specific phosphodiesterase inhibitors
E. Bollen et al.
NEUROPHARMACOLOGY (2015)
Synaptic Therapy in Alzheimer's Disease: A CREB-centric Approach
Andrew F. Teich et al.
NEUROTHERAPEUTICS (2015)
New insights concerning insulin synthesis and its secretion in rat hippocampus and cerebral cortex: Amyloid-β1-42-induced reduction of proinsulin level via glycogen synthase kinase-3β
Takayuki Nemoto et al.
CELLULAR SIGNALLING (2014)
Neuroprotective effect of tadalafil, a PDE-5 inhibitor, and its modulation by L-NAME in mouse model of ischemia-reperfusion injury
Puja Gulati et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase
Virginie Buggia-Prevot et al.
MOLECULAR NEURODEGENERATION (2014)
Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
George S. Bloom
JAMA NEUROLOGY (2014)
Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease
Serge Gauthier et al.
ALZHEIMERS & DEMENTIA (2013)
Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD
Carolina Garcia-Barroso et al.
NEUROPHARMACOLOGY (2013)
Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease
Chris G. Parsons et al.
NEUROTOXICITY RESEARCH (2013)
Cyclic AMP response element-binding protein (CREB) phosphorylation: A mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics
R. Scott Bitner
BIOCHEMICAL PHARMACOLOGY (2012)
BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's disease
Linda Chami et al.
MOLECULAR NEURODEGENERATION (2012)
Effects of sildenafil and tadalafil on ischemia/reperfusion injury in fetal rat brain
Ozlem Ozdegirmenci et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2011)
Preparation and characterization of toxic A beta aggregates for structural and functional studies in Alzheimer's disease research
Asad Jan et al.
NATURE PROTOCOLS (2010)
Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment
Francesca Mangialasche et al.
AGEING RESEARCH REVIEWS (2009)
The ratio of monomeric to aggregated forms of Aβ40 and Aβ42 is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity
Asad Jan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Share Paper
